2022 annual financial data
Whitehawk Therapeutics 2022 Operating margin
Direct answer
Operating margin was -411.94%.
Operating income was -62,681,000 USD and net income was -60,513,000 USD.
Operating cash flow was -49,640,000 USD.
Get free Whitehawk Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,216,000 USD
- Operating income
- -62,681,000 USD
- Net income
- -60,513,000 USD
- Operating cash flow
- -49,640,000 USD